Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy. - Zhang M; Yuan H; Pan X; Li X; Wang Z; Zhang S; Gu Z; Hu B; Qu X; Wang Q; Gu X; Wang B; et al. (Frontiers in immunology, 2026)